on 06 Dec 2022
Last Applicant/ Owned by
215 First Street
Cambridge
MA
02142
Serial Number
88829932 filed on 11th Mar 2020
Registration Number
6918743 registered on 06th Dec 2022
Correspondent Address
Paul C. Llewellyn
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
The mark consists of an abstract representation of the DNA double helix structure in maroon and gold. The color(s) maroon and gold is/are claimed as a feature of the mark. pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on mRead More
pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapies for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases
19th Sep 2016
19th Sep 2016
No 88829932
No Service/Collective Mark
No 1053686-0002
No
No
No
No
No
No
No
No
26.01.29 -
Helixes
The mark consists of an abstract representation of the DNA double helix structure in maroon and gold.
| Status Date | Action Taken |
|---|---|
| 06th Dec 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 06th Dec 2022 | REGISTERED-PRINCIPAL REGISTER |
| 03rd Nov 2022 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 02th Nov 2022 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 01st Nov 2022 | STATEMENT OF USE PROCESSING COMPLETE |
| 31st Oct 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 14th Oct 2022 | USE AMENDMENT FILED |
| 14th Oct 2022 | TEAS STATEMENT OF USE RECEIVED |
| 09th Sep 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 07th Sep 2022 | SOU EXTENSION 4 GRANTED |
